Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Amortization of Deferred Charges: 2023-2025

Historic Amortization of Deferred Charges for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $1,000.

  • Camp4 Therapeutics' Amortization of Deferred Charges fell 94.74% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $32,000, marking a year-over-year decrease of 67.35%. This contributed to the annual value of $83,000 for FY2024, which is 9.78% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Amortization of Deferred Charges of $1,000 as of Q3 2025, which was up 101.05% from -$95,000 recorded in Q2 2025.
  • Camp4 Therapeutics' Amortization of Deferred Charges' 5-year high stood at $111,000 during Q1 2025, with a 5-year trough of -$95,000 in Q2 2025.
  • Its 3-year average for Amortization of Deferred Charges is $16,250, with a median of $20,500 in 2024.
  • The largest annual percentage gain for Camp4 Therapeutics' Amortization of Deferred Charges in the last 5 years was 311.11% (2025), contrasted with its biggest fall of 531.82% (2025).
  • Camp4 Therapeutics' Amortization of Deferred Charges (Quarterly) stood at $30,000 in 2023, then crashed by 50.00% to $15,000 in 2024, then plummeted by 94.74% to $1,000 in 2025.
  • Its Amortization of Deferred Charges was $1,000 in Q3 2025, compared to -$95,000 in Q2 2025 and $111,000 in Q1 2025.